Physician Wealth Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Physician Wealth Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.78K	Hold	16	–	–	﹤0.01%	1551
2026 Q1	$1.39K	Hold	16	–	–	﹤0.01%	1510
2025 Q4	$1.71K	Hold	16	–	–	﹤0.01%	1359
2025 Q3	$1.62K	Hold	16	–	–	﹤0.01%	1319
2025 Q2	$1.01K	Buy	+16	New	+$980	﹤0.01%	1417

Other funds holding RYTM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

Physician Wealth Advisors's RYTM Position: Q2 2026 in Review

Physician Wealth Advisors held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 16 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Physician Wealth Advisors first reported a position in RYTM in Q2 2025 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Physician Wealth Advisors held 16 shares of Rhythm Pharmaceuticals worth $1.78K as of Q2 2026.
Physician Wealth Advisors left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
Rhythm Pharmaceuticals made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1551 holding.
Physician Wealth Advisors first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
61 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.